ArticleBMC cardiovascular disorders2025
Impact of iron deficiency on health-related quality of life and functional status in adults with chronic heart failure in Nigeria.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Clinical Correlates of Iron Deficiency in Vietnamese Patients with Chronic Heart Failure.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIron deficiency (ID) has been associated with poor quality of life in chronic heart failure (HF) patients, especially among Whites. Reports are, however, scarce among Africans on the impact of ID in chronic HF among Black Africans. This study aimed to describe the impact of ID on the quality of life among Africans with chronic HF, using the KCCQ-12 instrument.
methodsOne hundred and forty (140) subjects with HF were recruited from the cardiology Units of LAUTECH and Bowen University Teaching Hospital, Ogbomoso, Nigeria. ID was defined by standardized criteria. KCCQ-12 was used to assess the quality of life among the participants. Statistical analysis was done using SPSS-25.0. P < 0.05 was taken as statistically significant.
resultsID was present in 60% of the study participants. Patients with ID performed worse than patients with normal iron status in the Six-minutes walk test distance (6MWTD) in the study. They also scored significantly lower in symptom frequency score, physical limitation score (67.1 ± 27.6 vs. 78.6 ± 17.3 respectively, p < 0.05), clinical summary score (67.1 ± 26.7 vs. 78.3 ± 16.3, respectively p < 0.05), and social limitation score (70.1 ± 39.2 vs. 82.4 ± 25.9 respectively, p < 0.05), compared to those with normal iron status denoting worse quality of life. The mean 6MWTD was 180.3 ± 89.3 m among ID vs. 256.0 ± 100.3 m, p < 0.001 in normal iron status participants.
conclusionThis study shows that ID is associated with worse functional capacity and the quality of life among HF subjects in Nigeria, irrespective of anaemia status. Treatment of ID in HF is a potential way to improve morbidity and mortality among Africans with HF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.